ACAT1 and hyperlipidemia: Our work identified miR-21a-5p as a potential regulator of aerobic exercise affecting lipid metabolism, achieved the favorable goal in hyperlipidemia by synergistically inhibiting the expression of target genes FABP7, HMGCR, ACAT1, and OLR1.